MergerLinks Weekly Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Bain, Cinven pick banks for €10bn Stada exit.?
Bain Capital considers US LBM sale at $7bn.?
You can access today’s complete newsletter here.
Scroll down for more...
A consortium of investors, including Elliott, Patient Square Capital, and Veritas Capital, completed the acquisition of Syneos Health , a healthcare company, for $7.1bn.
"The company has a strong operating foundation, differentiated, integrated solutions and a focus on being committed to customers. We believe this transaction will enable Syneos Health to continue to accelerate its growth strategy, enhance customer delivery and evolve the organization toward a tech-enabled future," John Dineen, Syneos Health Chairman.
Syneos Health was advised by Bank of America , Centerview Partners , Ernst & Young, Latham & Watkins (led by Thomas Malone, Josh Dubofsky and Javier F. Stark) and Joele Frank (led by Tim Ragones, Jim Golden and Viveca Tress). Financial advisors were advised by Freshfields Bruckhaus Deringer (led by Damien R. Zoubek). Patient Square was advised by Borden Ladner Gervais LLP (BLG) (led by Ryan Tomicic), Kirkland & Ellis (led by Daniel E. Wolf, Michael E. Weisser and Maggie D. Flores). Veritas Capital was advised by Covington & Burling LLP ?(led by Scott A. Freling) and Milbank LLP (led by Richard Presutti and Lowell Dyer). Elliott was advised by UBS , AZB & Partners (led by Divya Mundra), Borden Ladner Gervais LLP (BLG) , Gibson, Dunn & Crutcher - Dubai (led by Richard Birns) and Pérez-Llorca (led by Francisco Iso). Debt financing was provided by BMO Capital Markets , Citi , Goldman Sachs , HSBC , JEFFERIES & COMPANY LIMITED , Macquarie Group , Natixis Partners , RBC Capital Markets, Truist Securities , UBS ?and Wells Fargo.
Advent and , two private equity investors, completed the acquisition of the BioPharma Solutions business of Baxter International Inc. , a global medtech company, for $4.25bn.
“Today represents an important step in Baxter’s ongoing transformation journey as we continue to execute against our strategic priorities, enhance our focus and create additional value for all our stakeholders. BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. Advent International and Warburg Pincus have extensive experience helping innovative healthcare companies advance their mission and strategic priorities. I am confident that under their stewardship, BPS will continue to build on its leadership position, foster world-class talent, invest in new capabilities and capacity, and provide leading-edge, high-quality solutions for its clients," José E. Almeida, Baxter Chairman, President and CEO.?
Advent International was advised by Moelis & Company , Cleary Gottlieb Steen & Hamilton LLP (led by Paul Imperatore, David Leinwand, and Matthew P. Salerno), Hengeler Mueller (led by Elisabeth Kreuzer and Daniel Wiegand),?and FGS Global (led by Kevin Siegel). Warburg Pincus was advised by Truist Securities , Ropes & Gray LLP (led by Christian Westra and Annie Sipe). Baxter was advised by Perella Weinberg and Sullivan & Cromwell LLP (led by Melissa Sawyer).
GTCR LLC , a private equity firm, completed the acquisition of the commercial business of ADT , a company that provides residential, small and large business electronic security, fire protection, and other related alarm monitoring services, for $1.6bn.
"Everon has a longstanding reputation for excellence in service and we look forward to continuing that legacy through strategic M&A, investing in technology to support innovation, and expanding Everon's portfolio of best-in-class solutions," Tom Ehrhart , GTCR Principal.
GTCR was advised by Raymond James (led by Alper Cetingok), Stifel Financial Corp. (led by Zeeshan Memon and Jeff Pranaitis) and Kirkland & Ellis (led by Daniel A. Guerin, Kyle P. McHugh and Stephen Ritchie). ADT was advised by Citi, RBC Capital Markets and Cravath, Swaine & Moore LLP (led by Sanjay Murti, Robert I. Townsend and Keith Hallam).
Bain, Cinven pick banks for €10bn Stada exit.
Bain Capital and Cinven have lined up banks to help them weigh options for STADA ?sterreich , including a potential sale of the German drugmaker, Bloomberg reported.
The private equity owners have picked Jefferies , J.P. 摩根 , 摩根士丹利 and Rothschild & Co .
Bain Capital considers US LBM sale at $7bn.?
Bain Capital is considering a sale of a minority stake in US LBM that could value the building materials group at about $7bn or more, including debt,?Bloomberg?reported.
The company is working with an adviser to run an auction process for a 49% stake. The stake is likely to interest other private equity firms.
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here.